Human Mature PCSK9 (153-692) Protein (Human Mature PCSK9 (153-692)) Ser 153 - Gln 692 (Accession # AAI66619) was produced in human 293 cells (HEK293) at ACROBiosystems.
Human Mature PCSK9 (153-692) is fused with a polyhistidine tag at the C-terminus, and has a calculated MW of 58 kDa. The predicted N-terminus is Ser 153. The reducing (R) protein migrates as 62 kDa in SDS-PAGE due to glycosylation.
Less than 1.0 EU per μg by the LAL method.
>97% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 10 mM HCl, pH2.4. Normally Trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4°C); After reconstitution under sterile conditions for 3 months (-70°C).
Human Mature PCSK9 (153-692) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
Proprotein convertase subtilisin/kexin type 9 (PCSK9), is an enzyme which in humans is encoded by the PCSK9 gene.This gene encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. PCSK9 may also have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a rare form of autosomal dominant familial hypercholesterolemia (HCHOLA3).
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.